Home / KEEP BUT DO NOT DISPLAY / Alerts (page 20)


Ordered by most recent

GlucoPro Insulin Syringes Voluntarily Recalled

GlucoPro Insulin Syringes Voluntarily Recalled A voluntary nationwide recall of all GlucoPro Insulin Syringes (Nipro Medical Corporation) is underway, according to a US Food and Drug Administration (FDA) notification to healthcare professionals. The alert notes that syringes may have needles that detach from the syringe. “If the needle becomes detached …

Read More »

Newsflashes #506

Novo Nordisk’s Once A Day Victoza(R) Receives FDA Approval for Adults with Type 2 Diabetes. Sibutramine Contraindicated in Patients with a History of Cardiovascular Disease — Sibutramine, marketed as Meridia in the US by Abbott, is now contraindicated in patients with a history of cardiovascular disease, the FDA announced. FDA …

Read More »


New NIH Study Results Show Intensive Control Reduces Complications by More Than 50% – See This Week’s Item #1

Read More »

Newsflash Issue 476

Medtronic Diabetes is voluntarily recalling Quick-set® infusion sets that have lot numbers starting with the number “8”. These infusion sets are used with MiniMed Paradigm® Insulin Pumps. The action was taken because of a situation related to the tubing connector which may not allow the insulin pump to vent properly. …

Read More »

Newsflash Issue 475

POSSIBLE LINK BETWEEN INSULIN GLARGINE AND CANCER QUESTIONED –  MORE RESEARCH REQUIRED Experts stress patients should not stop using insulin and consult their doctor if concerned.  See This Week’s Item 1 Takeda’s Diabetes Drug Alogliptin Rejected by FDA  Asia’s biggest drugmaker, Takeda, failed to gain U.S. regulatory approval to market …

Read More »

Newsflash Issue 473

The FDA has informed us that some stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc., are being sold in the U.S. market. They may not have been stored and handled properly, and may be dangerous for patients to use. The agency is advising patients who use …

Read More »

Newsflash Issue 472

ADA confirms that the A1c test will be used for the diagnosis of diabetes. Fasting blood sugar tests will no longer be necessary to diagnosis diabetes. The A1c test can be done anytime without regard to meals. ADA – International Expert Committee Recommends A1c Test to Diagnose Diabetes

Read More »